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Abstract
Background:   Tabebuia avellanedae is a tree from the Bignoniaceae family. Commonly know as
"pau d'arco" in Brazil, its inner bark is used as analgesic, anti-inflammatory, antineoplasic and
diuretic at the Brazilian northeast. A validation of the plant usage has not been previously
performed.
Results:  Antinociceptive and antiedematogenic effects of Tabebuia avellanedae Lor. ex Griseb. inner
bark were measured by nociceptive experimental models in mice. A rat paw edema test induced
by carrageenan (1%) was also performed in rats to access the plant's antiedematogenic effect. The
inner bark aqueous extract, administered via oral in three different concentration, namely 100, 200
and 400 mg/Kg, reduced the nociception produced by acetic acid (0.6% in water, i.p.) by 49.9%,
63.7% and 43.8%, respectively. The aqueous extract (200 and 400 mg/Kg, p.o.) reduced formalin
(1%) effects only at the second phase of the experiment by 49.3% and 53.7%, respectively.
Naloxone (5 mg/Kg, i.p.) was not able to revert the extract effect, however caffeine (10 mg/Kg, i.p.)
reverted its effect by 19.8% at the second phase of the formalin test. The aqueous extract (200 mg/
Kg, p.o.) inhibited edema by 12.9% when we used the rat paw edema model. The acute toxicity was
low in mice.
Conclusion:  The T. avellanedae inner bark aqueous extract presented antinociceptive and
antiedematogenic activities at the used models, with a possible antinociceptive effect associated to
the adenosine system.
Background
Tabebuia avellanedae is a tree from the Bignoniaceae
family. Commonly know as "pau d'arco" in Brazil, its in-
ner bark is used as analgesic, anti-inflammatory, antine-
oplasic [1,2] and diuretic at the Brazilian northeast. Its
anti-inflammatory, antimicrobial, and antineoplasic ac-
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ponines, flavonoides, cumarines, and natural antibiotics,
such as the lapachol and its derivatives encountered on
its constituents [3–6]. The antifungal activity of aque-
ous, dichloromethane and methanol extracts from T.
avellanedae and other 13 Paraguayan plants were ac-
cessed by Portillo et al. [7]. The aqueous and methanol
extracts of T. avellanedae showed the highest antifungal
activity. Phytochemical studies revealed the presence of
naphthoquinones, anthraquinones and quinoid com-
pounds in T. avellanedae, although lapachol, previously
cited as anti-inflammatory [8], was not detected in its
aqueous extract [9]. Since T. avellanedae inner bark is
extensively used as analgesic in Brazil, the goal of our
work was to describe the antiedematogenic and antinoc-
iceptive effects and acute toxicity of T. avellanedae inner
bark aqueous extract on various animal models.
Results
The inhibition of rat paw edema induced by carrageenan
was significantly different between all groups (ANOVA:
F0.05;3;140 = 45.72; p < 0.0005) and time intervals tested
(ANOVA: F0.05;4;140 = 35.66; p < 0.0005) The volume
variation was not proportional between all groups (ANO-
VA: F0.05;12;140 = 1.94; p < 0.05). The T. avellanedae
aqueous extract inhibited edema only at the 200 mg/Kg
dose (Tukey: q0.05;140;4 = 5.02; p < 0.05, Table 1). This
test is used to evaluate anti-inflammatory drugs and has
been used to test the antiedematogenic effect of various
substances [10].
When performing an writhing test, results showed nota-
ble differences at the writhing frequency between all
tested groups (Kruskal-Wallis: F0.05;5;47 = 9.26; p <
0.0005). T. avellanedae (100, 200 and 400 mg/Kg, p.o.)
reduced the acetic acid effect (Nemenyi: q0.05;∞;6 = 4.28,
p < 0.05 and q0.05;∞;6 = 4.17, p < 0.05, respectively, Table
2). The abdominal constriction response is an unspecific
nociception model used to evaluate the central and pe-
ripheral analgesics drug activities [11].
Our experiments showed significant differences between
four groups when the reaction time was taken into ac-
count at the formalin 1% test during the first and second
phases (Kruskal-Wallis: F0.05;4;34 = 22.52; p < 0.0005
and F0.05;4;34 = 23.45; p < 0.0005, respectivelly). The
aqueous extract of T. avellanedae (200 e 400 mg/Kg) re-
duced the formalin effect only at the second phase
(Nemenyi: q0,05;∞;5 = 4.264, p < 0.05 and q0,05;∞;5 =
4.643, p < 0.05, Table 3).
Naloxone (5 mg/Kg, i.p.) did not revert the action of the
aqueous extract (400 mg/Kg) (Nemenyi: q0.05;∞;3 =
4.27; p < 0.05). Caffeine, an adenosine A1 and A2 recep-
tors antagonist, reverted the T. avellanedae aqueous ex-
tract action at the formalin test second phase (Nemenyi:
q0.05;∞;3 = 1.45; p > 0.05, Table 3). There was no LD50
when using doses up to 5000 mg/Kg.
Discussion
The aqueous extract at 200 mg/Kg inhibited the rat paw
edema induced by carrageenan in a similar way as in-
domethacin (Table 1). However at 400 mg/Kg we did not
detect edema reduction. It would be expected a dose-de-
pendent effect when using higher concentrations. Since
the aqueous extract contains several compounds, anoth-
er compound in the extract may be acting simultaneously
to revert its own action.
Table 1: Effects of control, T. avellanedae aqueous extract (AE, 200 and 400 mg/Kg), and indomethacin (10 mg/Kg) at the rat paw edema 
induced by carrageenan 1%. The paw volume was measured four times with 1 h intervals between them. It is shown these intervals and 
the inhibition percentages for each interval.
Average ± SE (mL)
Treatment Dose
1 h % 2 h % 3 h % 4 h %
(p.o.) (mg/Kg)
Control - 1.33 ± 0.06 - 1.60 ± 0.14 - 1.69 ± 0.12 - 1.7 ± 0.12 -
Indomethacin 10 0.82 ± 0.02a 38.6 0.88 ± 0.02a 45.0 0.97 ± 0.06a 42.5 1.0 ± 0.07a 41.3
AE 200 1.13 ± 0.06a 15.6 1.33 ± 0.06a 16.7 1.47 ± 0.05a 12.7 1.46 ± 0.05a 14.0
AE 400 1.2 ± 0.04 9.8 1.5 ± 0.07 6.7 1.65 ± 0.08 2.3 1.61 ± 0.08 5.4
%, edema inhibition percentage (n = 8/group). SE, average standard error. ap < 0.05 compared to control (Anova, followed by Tukey).
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represent a peripheral nociception model [12], this is not
a specific model, since several compounds, such as, tricy-
clic antidepressants [13] and anti-histaminic [14] inhibit
the writhes induce by acetic acid. Even though the T.
avellanedae AE prevented the writhes, there is still the
need for studies using other analgesia models.
Three distinct phases are involved on the acute vascular
response. At the first phase simultaneous release of his-
tamine and serotonin occurs. At the second phase kinin
release, such as bradykinin, occurs and at the terminal
phase prostaglandins release occurs [15]. Any substance
inhibiting the carrageenan action at the used model is
considered as having anti-inflammatory action.
Since the effect of the AE was not reverted by naloxone at
the formalin test second phase, our studies indicate that
the opioid system does not participate at the AE (200
and 400 mg/Kg) pharmacological properties. On the
other hand caffeine reverted the AE action at the forma-
lin test second phase, suggesting the participation of the
adenosine system at the analgesic effect. Adenosine may
interact with at least four subtipes of receptors coupled
with protein G, namely A1, A2a, A2b, and A3[16]. There
has been evidences that activation of the A1 and A2 recep-
tors produce an antinociceptive effect, while activation of
the A3 receptor produce nociception [17]. These facts are
supported by experiments where caffeine produced anti-
nociception [16]. Henceforth the AE antinociceptive ef-
fect at the formalin test second phase may be associated
to an activation of the A1 and/or A2 adenosine receptors.
Further studies are needed to confirm these findings.
The formalin test is one of the most used models to ex-
plain pain and analgesia mechanisms, with better results
than the ones using mechanical or thermal stimulus [18].
This model is constituted by two distinct phases. The
first phase represents the irritating effect of formalin at
the sensorial fibers-C. The second is an inflammatory
pain response. Central acting analgesics, such as mor-
phine, inhibit both phases. Peripheral acting drugs, such
as non-steroid anti-inflammatory and corticosteroids,
inhibit only the second phase [19].
Table 2: Effects of control, T. avellanedae aqueous extract (AE, 
100, 200, and 400 mg/Kg), indomethacin (10 mg/Kg), and mor-
phine (2.5 mg/Kg) at the writhes induced by acetic acid 0.6%. The 
number of writhes median is shown in the third column, followed 
by inhibition percentages.
Treatment Dose (mg/Kg) Median %
Control - 29 -
Indomethacin (p.o.) 10 2a 65.1
Morphine (i.p.) 2.5 3a 52.6
AE (p.o.) 100 7a 44.9
AE (p.o.) 200 3a 63.7
AE (p.o.) 400 4a 43.8
n = 9 per group. %, writhing inhibition percentage. ap < 0.05, compared 
to control (Kruskal-Wallis, followed by Nemenyi).
Table 3: Effect of T. avellanedae aqueous extract (AE, 100, 200, and 400 mg/Kg) and morphine at the formalin 1% test. The results of the 
AE at the analgesia model induced by formalin are shown as the median of the time, which each mouse spent licking its posterior left 
paw after administration of formalin (1%) and its respective percentage. The AE (200 and 400 mg/Kg) significantly reduced the second 
phase of the formalin test.
1st phase 2nd phase
Treatment Dose (mg/Kg) Median % Median %
Control - 58.5 - 36 -
Morphine (i.p.) 7.5 10.5a 87 0a 81.8
AE (p.o.) 100 45 38 16 28.5
AE (p.o.) 200 43 43.1 6a 49.3
AE (p.o.) 400 38 43.1 1a 53.7
Morphine (i.p.)+Naloxone (i.p.) 5 55.5 16.5 18a 33.8
Naloxone (i.p.)+AE400 5 37a 62.8 3a 71.4
Caffeine (i.p.)+AE400 10 44a 55 26.5 19.8
%, pain reaction time inhibition percentage. ap < 0.05 compared to control (Kruskal-Wallis, followed by Nemenyi), AE400, aqueous extract 400 mg/
Kg.
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lack of mice deaths even at high concentration of the T.
avellanedae aqueous extract. This result indicates that
the plant has a low toxicity profile [20]. The plant pre-
sented antiedematogenic and antinociceptive at the pe-
ripheral system, probably due to its action at mediators,
such as bradykinin and prostaglandins at the neuron ter-
mination. Hiperalgesy may also be involved on this proc-
ess, mediated by the adenosine A2 receptor [21,22].
Conclusion
Tabebuia avellanedae is used by popular medicine as
anti-inflammatory, antimicrobial, antineoplasic, and di-
uretic. The T. avellanedae inner bark aqueous extract
presented antinociceptive and antiedematogenic activi-
ties at the used models, with the antinociceptive effect
associated to the adenosine system. These results vali-
date the plant popular use as analgesic and antiinflam-
matory. The antimicrobial, antineoplasic, and diuretic
activities were not studied.
Materials and Methods
Plant material
The Tabebuia avellanedae inner bark collected at the
"Capim Grosso" village (Canindé do São Francisco re-
gion) was used. The plant identification was made on site
by our herbalist (Gilvane V. Souza, Biology Department)
and a voucher specimen number 2955 was deposited at
the University of Sergipe herbarium, (Universidade Fed-
eral de Sergipe, CCBS, Departamento de Biologia, São
Cristovão, Sergipe, 49100–000, Brazil).
Aqueous extract preparation
The plant inner barks were dried at 40°C in oven and trit-
urated using a mill in order to obtain a powder. Distilled
water (1:10 w/v) at 100°C was added to the triturated
powder, constituting the aqueous extract. The extract
was infused for 30 min, filtered, lyophilized and used on
the pharmacological tests. The yield of the aqueous ex-
tract was 8.9% w/w. In order to perform all experiments
the extract was reconstituted in enough water to make a
100 mg/mL solution and administered p.o. 60 minutes
before the experiment.
Animals
Swiss mice (20–35 g) and Wistar rats (120–200 g) male
and female were used as test animals. The animals were
maintained in plastic boxes, with food and water ad libi-
tum. The animals submitted to oral administration of the
extract or drugs were fasted for 12 hours.
Drugs preparation
Drugs used in the experiments were diluted in a way to
obtain a injection volume of 0.1 mL/10 g (animal
weight), except when defined in the text. Each drug was
dissolved in appropriate solvents as follows: Indometh-
acin (Sigma), diluted in water/0.1 N NaOH (pH = 8); car-
rageenan 1% (Sigma), in saline solution; acetic acid 0.6%
(Merck), in water; Morphine hydrochloride (Sigma) in
water; formalin 1% (Baker) in water; naloxone hydro-
chloride (Sigma), in water; caffeine (Sigma) in water.
Acute toxicity (LD50)
In order to verify the plant LD50, mice (n = 10) received
the aqueous extract (1, 3 and 5 g/Kg; p.o.). The mortality
index was observed during 48 hours [20].
Rat paw edema test
The antiedematogenic activity was evaluated by the rat
paw edema test[10] (n = 8) induced by carrageenan at 1%
in. Indomethacin (10 mg/Kg; p.o.) and the T. avellane-
dae aqueous extract (200 and 400 mg/Kg; p.o.) were ad-
ministered 1 h before the flogistic agent subplantar
injection. The control group received only the carrageen-
an injection. The paw volume was measured at the time
0, then measured again 1, 2, 3, and 4 h after the carra-
geenan administration by the water displacement meth-
od measured with the help of a plethysmometer (model
7150, Ugo Basile).
Writhing test
The antinociceptive effect was evaluated by the writhing
test [11] in mice (n = 9), induced by acetic acid 0.6% (0.1
mL/10 g; i.p.). The T. avellanedae aqueous extract (100,
200 and 400 mg/Kg; p.o.) was administered 1 h before
the nociceptive agent. Ten minutes after the acid admin-
istration we observed the number of writhes for a period
of 20 min. Morphine (2.5 mg/Kg, i.p.) and indomethacin
(10 mg/Kg, p.o.) were used as test standards.
Formalin test
The antinociceptive effect was also evaluated by the for-
malin test. It was observed the time (seconds), which
each mice (n = 8) spent licking its posterior left paw after
administration, subplantar route, of formalin 0.02 mL,
1% [19,23]. The T. avellanedae aqueous extract (100,
200 and 400 mg/Kg; p.o.) was administered 1 h before
the formalin injection. The standard test drug was mor-
phine (7.5 mg/Kg, i.p.). The reaction time to pain was
measured during 0–5 min and 20–25 min after the stim-
ulus. In order to verify a possible opioid system partici-
pation, naloxone (5 mg/Kg; i.p.) was administered with
the AE to another animal group (n = 8, Table 3). In a sim-
ilar way caffeine (10 mg/Kg; i.p.) was administered with
the AE to verify possible adenosine system receptor par-
ticipation. Morphine and naloxone were also adminis-
tered to another animal group.
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The inflammation test results were analyzed by ANOVA
followed by the Tukey test. In order to analyze the nocic-
eption model we used the non-parametrical analogous
test, the Kruskal-Wallis followed by the Nemenyi test,
with a significance level of 5%. Inhibition percents were
calculated by the formula: Inhibition percent = (1 -Vt/
Vc)×100, where Vt and Vc represent the average paw vol-
ume, the number of writhes, or the licking paw time of
the treated and control groups, respectively.
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